b cell lymphomas
Showing 1 - 4 of 4
B Cell Leukemias, B Cell Lymphomas Trial in Philadelphia (CART22 cells transduced with a lentiviral vector to express anti-CD22
Recruiting
- B Cell Leukemias
- B Cell Lymphomas
- CART22 cells transduced with a lentiviral vector to express anti-CD22 scFv TCRz:41BB
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jan 19, 2022
Subjects Treated With ACTR T Cell Product
Terminated
- B Cell Lymphomas
- +3 more
- ACTR T Cell Product
-
Gilbert, Arizona
- +15 more
Oct 4, 2021
B Cell Lymphomas Trial in Durham (Nivolumab, Microtransplantation)
Withdrawn
- B Cell Lymphomas
- Nivolumab
- Microtransplantation
-
Durham, North CarolinaDuke University
Mar 19, 2021
11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),, Prolymphocytic Leukaemia (PLL), B Cell Lymphomas Trial in
Completed
- 11q-deleted Relapsed/Refractory Chronic Lymphocytic Leukaemia (CLL),
- +2 more
- Administration of AZD6738
-
La Jolla, CaliforniaResearch Site
Jun 18, 2014